Teva Pharma Industries Stock Price on November 27, 2024

TEVA Stock  USD 16.78  0.21  1.27%   
Below is the normalized historical share price chart for Teva Pharma Industries extending back to November 07, 1984. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Teva Pharma stands at 16.78, as last reported on the 1st of December, with the highest price reaching 16.96 and the lowest price hitting 16.37 during the day.
IPO Date
26th of March 1990
200 Day MA
16.2317
50 Day MA
17.595
Beta
0.868
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Teva Stock, it is important to understand the factors that can impact its price. Teva Pharma Industries owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0777, which indicates the firm had a -0.0777% return per unit of risk over the last 3 months. Teva Pharma Industries exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Teva Pharma's Risk Adjusted Performance of (0.05), variance of 3.14, and Coefficient Of Variation of (1,294) to confirm the risk estimate we provide.
  
At present, Teva Pharma's Total Stockholder Equity is projected to decrease significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 24.9 B, whereas Common Stock Shares Outstanding is forecasted to decline to about 777 M. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.34, whereas Price To Sales Ratio is forecasted to decline to 0.70. Teva Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0777

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsTEVA

Estimated Market Risk

 1.78
  actual daily
15
85% of assets are more volatile

Expected Return

 -0.14
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.08
  actual daily
0
Most of other assets perform better
Based on monthly moving average Teva Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Teva Pharma by adding Teva Pharma to a well-diversified portfolio.
Price Book
3.1348
Enterprise Value Ebitda
22.8158
Price Sales
1.1336
Shares Float
1.1 B
Wall Street Target Price
22.3644

Teva Pharma Main Headline on 27th of November 2024

BioMarin Pharmaceutical, Alexion Pharmaceuticals, Amgen, Eli Lilly Company, and Novartis Dominate the Competitive Landscape Skeletal Dysplasia Market Skeletal Dysplasia Market Dublin, Nov. 27, 2024 -- The Skeletal Dysplasia Market by Type, Treatment, End User - Global Forecast 2025-2030 report has been added to ResearchAndMarkets.coms offering.The Skeletal Dysplasia Market grew from USD 2.83 billion in 2023 to USD 3.03 billion in 2024. It is expected to continue growing at

Teva Pharma Valuation on November 27, 2024

It is possible to determine the worth of Teva Pharma on a given historical date. On November 27, 2024 Teva was worth 16.54 at the beginning of the trading date compared to the closed value of 16.57. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Teva Pharma stock. Still, in general, we apply an absolute valuation method to find Teva Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Teva Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Teva Pharma's related companies.
 Open High Low Close Volume
  16.50    16.67    16.40    16.59    8,369,360  
11/27/2024
  16.54    16.69    16.45    16.57    9,728,122  
  16.46    16.96    16.37    16.78    5,067,832  
Backtest Teva Pharma  |  Teva Pharma History  |  Teva Pharma Valuation   PreviousNext  
Open Value
16.54
16.57
Closing Value
21.88
Upside

Teva Pharma Trading Date Momentum on November 27, 2024

On November 29 2024 Teva Pharma Industries was traded for  16.78  at the closing time. The top price for the day was 16.96  and the lowest listed price was  16.37 . The trading volume for the day was 5.1 M. The trading history from November 29, 2024 was a factor to the next trading day price jump. The trading price change against the next closing price was 1.27% . The trading price change against the current closing price is 0.66% .

Teva Pharma Industries Fundamentals Correlations and Trends

By evaluating Teva Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Teva Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Teva financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Teva Pharma Stock history

Teva Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Teva is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Teva Pharma Industries will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Teva Pharma stock prices may prove useful in developing a viable investing in Teva Pharma
Last ReportedProjected for Next Year
Common Stock Shares Outstanding1.1 B777 M
Net Loss-2.1 B-2 B

Teva Pharma Stock Technical Analysis

Teva Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Teva Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Teva Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Teva Pharma Period Price Range

Low
December 1, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Teva Pharma Industries cannot be verified against its exchange. Please verify the symbol is currently traded on New York Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Teva Pharma December 1, 2024 Market Strength

Market strength indicators help investors to evaluate how Teva Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Teva Pharma shares will generate the highest return on investment. By undertsting and applying Teva Pharma stock market strength indicators, traders can identify Teva Pharma Industries entry and exit signals to maximize returns

Teva Pharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Teva Pharma's price direction in advance. Along with the technical and fundamental analysis of Teva Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Teva to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Teva Stock analysis

When running Teva Pharma's price analysis, check to measure Teva Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharma is operating at the current time. Most of Teva Pharma's value examination focuses on studying past and present price action to predict the probability of Teva Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharma's price. Additionally, you may evaluate how the addition of Teva Pharma to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio